| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 1,429 | 1,668 | 1,686 | 1,762 |
| Cost of products sold | 833 | 924 | 948 | 955 |
| Gross profit | 596 | 744 | 738 | 807 |
| Selling and administrative expenses | 277 | 267 | 280 | 281 |
| Advertising costs | 166 | 207 | 191 | 201 |
| Research and development costs | 28 | 27 | 31 | 31 |
| Loss on divestiture | 0 | 0 | 0 | -118 |
| Pension settlement charge | - | 0 | 0 | - |
| Interest expense | 23 | 23 | 22 | 21 |
| Amortization of trademarks and other intangible assets | - | 5 | - | - |
| Trust investment (gains) losses, net | - | -2 | - | - |
| Net periodic benefit cost | - | 3 | - | - |
| Foreign exchange transaction (gains) losses, net | - | 1 | - | - |
| Income from equity investees | - | 0 | - | - |
| Interest income | - | 2 | - | - |
| Restructuring costs | - | 0 | - | - |
| Gain on sale-leaseback transaction | - | 0 | - | - |
| Cyberattack insurance recoveries | - | 33 | - | - |
| Other | - | -8 | - | - |
| Other (income) expense, net | -5 | -34 | -23 | -22 |
| Earnings before income taxes | 107 | 254 | 237 | 177 |
| Income tax expense | 25 | 63 | 43 | 74 |
| Net earnings | 82 | 191 | 194 | 103 |
| Less net earnings attributable to noncontrolling interests | 2 | 5 | 1 | 4 |
| Net earnings attributable to clorox | 80 | 186 | 193 | 99 |
| Basic (in shares) | 122,629,000 | 123,367,000 | 123,766,000 | 123,795,000 |
| Basic net earnings per share (in dollars per share) | 0.65 | 1.51 | 1.55 | 0.8 |
| Diluted (in shares) | 123,018,000 | 124,066,000 | 124,662,000 | 124,677,000 |
| Diluted net earnings per share (in dollars per share) | 0.65 | 1.5 | 1.54 | 0.8 |
CLOROX CO DE (CLX)
CLOROX CO DE (CLX)